Investigation of beta-blockers in preventing the exacerbation of retinopathy of prematurity

Phase 2

Recruiting

• Conditions: Retinopathy of prematurity.; Retinopathy of prematurity, stage 2; H35.13

• Registration Number: IRCT20230526058300N1
• Lead Sponsor: Karaj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

Gestational age less than 34 weeks
Premature infants between 26 weeks and 34 weeks, who underwent ophthalmic examination from the fourth to the twelfth week of birth and it was determined that they have stage 2 ROP and above.

Exclusion Criteria

Infants with congenital or acquired cardiac anomalies
ROP stage 1
Unstable hemodynamic

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determining the progression rate of retinopathy of prematurity 3 stage in babies with retinopathy 2 stage. Timepoint: weekly examination by ophthalmologist until discharge. Method of measurement: Retcam imaging system II.

Secondary Outcome Measures

Name	Time	Method
The rate of complete recovery of retinopathy of prematurity in infants with stage 2 retinopathy. Timepoint: Weekly examination by Ophthalmologist. Method of measurement: Retcam imaging system II.